← Back
Data updated: Mar 10, 2026
SHUANGCHENG
Cardiovascular
SHUANGCHENG is a generic drug manufacturer focused on Cardiovascular. Key products include BORTEZOMIB.
2019
Since
5
Drugs
-
Trials
31
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BORTEZOMIB 2026-01-06
BORTEZOMIB 2025-12-17
OCTREOTIDE ACETATE 2025-12-12
PACLITAXEL 2025-08-19
PACLITAXEL 2025-07-10
Labeling
EPTIFIBATIDE 2025-06-13
Labeling
BORTEZOMIB 2025-06-02
PACLITAXEL 2025-05-15
PACLITAXEL 2025-04-10
EPTIFIBATIDE 2025-03-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
2 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (1)
Company Info
- First Approval
- 2019-10-23
- Latest
- 2025-12-17
- Applications
- 5